These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 18331174

  • 1. Insulin glargine and glulisine SoloSTAR pens for the treatment of diabetes.
    Garg S, Kelly WC, Garg S.
    Expert Rev Med Devices; 2008 Mar; 5(2):113-23. PubMed ID: 18331174
    [Abstract] [Full Text] [Related]

  • 2. Dose accuracy and injection force dynamics of a novel disposable insulin pen.
    Clarke A, Spollett G.
    Expert Opin Drug Deliv; 2007 Mar; 4(2):165-74. PubMed ID: 17335413
    [Abstract] [Full Text] [Related]

  • 3. Comparison of usability and patient preference for the new disposable insulin device Solostar versus Flexpen, lilly disposable pen, and a prototype pen: an open-label study.
    Haak T, Edelman S, Walter C, Lecointre B, Spollett G.
    Clin Ther; 2007 Apr; 29(4):650-60. PubMed ID: 17617288
    [Abstract] [Full Text] [Related]

  • 4. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD, Camacho FT, Anderson RT, Cobden D, Joshi AV, Balkrishnan R.
    Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
    [Abstract] [Full Text] [Related]

  • 5. Initiating insulin therapy in type 2 diabetes: benefits of insulin analogs and insulin pens.
    Brunton S.
    Diabetes Technol Ther; 2008 Aug; 10(4):247-56. PubMed ID: 18715198
    [Abstract] [Full Text] [Related]

  • 6. Dose accuracy comparison between SoloSTAR and FlexPen at three different dose levels.
    Penfornis A, Horvat K.
    Diabetes Technol Ther; 2008 Oct; 10(5):359-62. PubMed ID: 18715211
    [Abstract] [Full Text] [Related]

  • 7. A review of insulin pen devices.
    McCoy EK, Wright BM.
    Postgrad Med; 2010 May; 122(3):81-8. PubMed ID: 20463417
    [Abstract] [Full Text] [Related]

  • 8. Insulin delivery by injection in children and adolescents with diabetes.
    Hanas R, de Beaufort C, Hoey H, Anderson B.
    Pediatr Diabetes; 2011 Aug; 12(5):518-26. PubMed ID: 21481121
    [Abstract] [Full Text] [Related]

  • 9. Validation of the SoloSTAR insulin pen.
    Schwartz S, Vlajnic A.
    Diabetes Technol Ther; 2008 Oct; 10(5):351-7. PubMed ID: 18715210
    [Abstract] [Full Text] [Related]

  • 10. Dosing accuracy with a novel pen device (SoloSTAR) as performed by patients with diabetes in a clinical setting.
    Hermanns N, Kulzer B, Haak T.
    Diabetes Technol Ther; 2008 Aug; 10(4):322-7. PubMed ID: 18715206
    [Abstract] [Full Text] [Related]

  • 11. Addressing barriers to insulin therapy: the role of insulin pens.
    Magwire ML.
    Am J Ther; 2011 Sep; 18(5):392-402. PubMed ID: 20838202
    [Abstract] [Full Text] [Related]

  • 12. Considerations for diabetes: treatment with insulin pen devices.
    Cuddihy RM, Borgman SK.
    Am J Ther; 2013 Sep; 20(6):694-702. PubMed ID: 21768872
    [Abstract] [Full Text] [Related]

  • 13. A Pan-European and Canadian prospective survey to evaluate patient satisfaction with the SoloSTAR insulin injection device in type 1 and type 2 diabetes.
    Hancu N, Czupryniak L, Genestin E, Sourij H.
    J Diabetes Sci Technol; 2011 Sep 01; 5(5):1224-34. PubMed ID: 22027323
    [Abstract] [Full Text] [Related]

  • 14. Insulin delivery with FlexPen: dose accuracy, patient preference and adherence.
    Pfützner A, Asakura T, Sommavilla B, Lee W.
    Expert Opin Drug Deliv; 2008 Aug 01; 5(8):915-25. PubMed ID: 18713000
    [Abstract] [Full Text] [Related]

  • 15. Does pen help? A real-world outcomes study of switching from vial to disposable pen among insulin glargine-treated patients with type 2 diabetes mellitus.
    Xie L, Zhou S, Wei W, Gill J, Pan C, Baser O.
    Diabetes Technol Ther; 2013 Mar 01; 15(3):230-6. PubMed ID: 23336845
    [Abstract] [Full Text] [Related]

  • 16. Ease of use and preference of a new versus widely available prefilled insulin pen assessed by people with diabetes, physicians and nurses.
    Oyer D, Narendran P, Qvist M, Niemeyer M, Nadeau DA.
    Expert Opin Drug Deliv; 2011 Oct 01; 8(10):1259-69. PubMed ID: 21905942
    [Abstract] [Full Text] [Related]

  • 17. Reusable and disposable insulin pens for the treatment of diabetes: understanding the global differences in user preference and an evaluation of inpatient insulin pen use.
    Perfetti R.
    Diabetes Technol Ther; 2010 Jun 01; 12 Suppl 1():S79-85. PubMed ID: 20515312
    [Abstract] [Full Text] [Related]

  • 18. Pen devices to improve patient adherence with insulin therapy in type 2 diabetes.
    Goldstein HH.
    Postgrad Med; 2008 Sep 01; 120(3):172-9. PubMed ID: 18824835
    [Abstract] [Full Text] [Related]

  • 19. Intensive insulin therapy and insulin pumps.
    Bode BW.
    Postgrad Med; 2002 Nov 01; 112(5 Suppl Designer):17-21. PubMed ID: 19667601
    [Abstract] [Full Text] [Related]

  • 20. Devices for insulin administration.
    Hill J.
    Nurs Times; 2002 Nov 01; 99(15):51-2. PubMed ID: 12733296
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.